– 2,450 participants (≈800 per virus cohort).

The story of ADN-388 serves as a testament to the dynamic, ever-changing nature of the internet, where mystery and intrigue can emerge at any moment, captivating the attention of enthusiasts and curious minds alike.

| Agent | Target | Spectrum | Oral Bioavailability | FDA Status | |-------|--------|----------|----------------------|------------| | | RdRp (SARS‑CoV‑2) | Narrow (CoV) | IV only | Approved (IV) | | Molnupiravir | RdRp (error inducer) | Narrow (CoV) | ~70% | Approved (oral) | | ADN‑388 | Conserved RdRp Motif C | Broad (≥15 RNA families) | ~80% | Conditional (COVID‑19) | | Favipiravir | RdRp (competitive) | Moderate (Flavivirus, Influenza) | 60% | Approved (Japan) |

ADN-388, a code so cold A secret recipe, young and old Genetic fire, burning bright Unlocking potential, a new light

White dots

Get to know Kleanlabs competitive prices!
Ask for inquiry